Form 4: ProKidney Corp Director Uma Sinha Granted Stock Options
SEC Form 4
Director Uma Sinha received stock options for 62,558 Class A Ordinary Shares in ProKidney Corp on May 30, 2024.
Summary
- Uma Sinha, a director of ProKidney Corp, was granted stock options on May 30, 2024.
- The options are for 62,558 Class A Ordinary Shares.
- The exercise price of the options is $4.20.
- The options vest in full on the sooner of the one-year anniversary of the grant date or the date of the company's next annual general shareholder meeting.
- The options expire on May 30, 2034.
Sentiment
Score: 6
Explanation: The document is a routine disclosure of stock option grants, which is neither particularly positive nor negative. It's a standard part of director compensation.
Positives
- The grant of stock options to a director aligns their interests with those of the shareholders.
Industry Context
Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders.
Stakeholder Impact
- The stock option grant aligns the director's interests with those of the shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 05/30/2024 | Date of the stock option grant |
| 05/30/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.